If you have a history of depression or anxiety, keeping your mental health provider informed while on a GLP-1 is sensible
Kieren Mather, MD, is vice president of medical incretin and diabetes breakthroughs in the early clinical research division at Eli Lilly, where he leads efforts to develop next-generation treatments for diabetes and metabolic disorders
Thus, accumulating evidence suggests that CB-839 is a promising anti-cancer drug whose tumor-suppressing activity is attributed to inhibiting the carbon branch of Gln metabolism
Moreover, in 6-OHDA lesioned rats, treatment with dual GLP-1/GIP analogues attenuated dopaminergic cells and motor deficits, while levels of the growth factor GDNF and pAkt/CREB cell signaling were enhanced [52]
Dozens sue saying Ozempic, other weight loss and diabetes drugs cause harmful side effects